Elizabeth A. Goodin

University of Otago

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

The hinge‐1 domain of Flna is not necessary for diverse physiological functions in mice

European Journal of Clinical Investigation (2024)

Emma M. Wade Elizabeth A. Goodin Tim Morgan Stephana Pereira Adele G. Woolley

Abstract Introduction The filamins are cytoskeletal binding proteins that dynamically crosslink actin into orthogonal networks or bundle it into stress fibres. The domain structure of filamin proteins is very well characterised, with an N‐terminal actin‐binding region, followed by 24 immunoglobulin‐like repeat units. The repeat domains are separated into distinct segments by two regions of low‐complexity known as hinge‐1 and hinge‐2. The role of hinge‐1 especially has been proposed to be essential for protein function as it provides flexibility to the otherwise rigid protein, and is a target for cleavage by calpain. Hinge‐1 protects cells from otherwise destructive forces, and the products of calpain cleavage are involved in critical cellular signalling processes, such as survival during hypoxia. Pathogenic variants in FLNA encoding Filamin A, including those that remove the hinge‐1 domain, cause a wide range of survivable developmental disorders. In contrast, complete loss of function of this gene is embryonic lethal in human and mouse. Methods and Results In this study, we show that removing filamin A hinge‐1 from mouse ( Flna ΔH1 ), while preserving its expression level leads to no obvious developmental phenotype. Detailed characterisation of the skeletons of Flna ΔH1 mice showed no skeletal phenotype reminiscent of that found in the FLNA‐ causing skeletal dysplasia. Furthermore, nuclear functions of FLNA are maintained with loss of Filamin A hinge‐1. Conclusion We conclude that hinge‐1 is dispensable for filamin A protein function during development over the murine lifespan.

FLNA

10.1111/eci.14308

Cite

Citations (0)

FLNA-filaminopathy skeletal phenotypes are not due to an osteoblast autonomous loss-of-function

Bone Reports (2023)

Emma M. Wade Elizabeth A. Goodin Yongqiang Wang Tim Morgan Karen E. Callon

Mutations in FLNA, which encodes the cytoskeletal protein FLNA, cause a spectrum of sclerosing skeletal dysplasias. Although many of these genetic variants are recurrent and cluster within the gene, the pathogenic mechanism that underpins the development of these skeletal phenotypes is unknown. To determine if the skeletal dysplasia in FLNA-related conditions is due to a cell-autonomous loss-of-function localising to osteoblasts and/or osteocytes, we utilised mouse models to conditionally remove Flna from this cellular lineage. Flna was conditionally knocked out from mature osteocytes using the Dmp1-promoter driven Cre-recombinase expressing mouse, as well as the committed osteoblast lineage using the Osx-Cre or Col1a1-Cre expressing lines. We measured skeletal parameters with μCT and histological methods, as well as gene expression in the mineralised skeleton. We found no measureable differences between the conditional Flna knockout mice, and their control littermate counterparts. Moreover, all of the conditional Flna knockout mice, developed and aged normally. From this we concluded that the skeletal dysplasia phenotype associated with pathogenic variants in FLNA is not caused by a cell-autonomous loss-of-function in the osteoblast-osteocyte lineage, adding more evidence to the hypothesis that these phenotypes are due to gain-of-function in FLNA.

FLNA

Conditional gene knockout

Gene knockout

Osteocyte

10.1016/j.bonr.2023.101668

Cite

Citations (1)

<i>FLNA</i>-Filaminopathy Skeletal Phenotypes are Not Due to an Osteoblast Autonomous Loss-of-Function

SSRN Electronic Journal (2022)

Emma M. Wade Elizabeth A. Goodin Yongqiang Wang Tim Morgan Karen E. Callon

Mutations in FLNA, which encodes the cytoskeletal protein FLNA, cause a spectrum of sclerosing skeletal dysplasias. Although many of these genetic variants are recurrent and cluster within the gene, the pathogenic mechanism that underpins the development of these skeletal phenotypes is unknown. To determine if the skeletal dysplasia in FLNA-related conditions is due to a cell-autonomous loss-of-function localising to osteoblasts and/or osteocytes, we utilised mouse models to conditionally remove Flna from this cellular lineage. Flna was conditionally knocked out from mature osteocytes using the Dmp1- promoter driven Cre-recombinase expressing mouse, as well as the committed osteoblast lineage using the Osx- Cre or Col1a1 -Cre expressing lines. We measured skeletal parameters with µCT and histological methods, as well as gene expression in the mineralised skeleton. We found no measurable differences between the conditional Flna knockout mice, and their control littermate counterparts. Moreover, all of the conditional Flna knockout mice, developed and aged normally. From this we concluded that the skeletal dysplasia phenotype associated with pathogenic variants in FLNA is not caused by a cell-autonomous loss-of-function in the osteoblast-osteocyte lineage, adding more evidence to the hypothesis that these phenotypes are due to gain-of-function in FLNA.

Loss function

FLNA

10.2139/ssrn.4056979

Cite

Citations (0)